IOL Chemicals Reports Record Q1 FY27 Revenue of ₹756.3 Cr

IOL Chemicals & Pharmaceuticals Ltd. announced its unaudited financial results for the quarter ended June 30, 2026, reporting a record quarterly performance with the highest-ever revenue of ₹756.3 Cr, a 37.1% year-on-year increase. EBITDA grew by 60.7% to ₹111.7 Cr, and PAT surged by 89.9% to ₹64.5 Cr. The Pharmaceuticals segment was a key growth driver, with revenue up 43% YoY and EBIT up 72% YoY. The Chemicals business also saw significant growth, with revenue up 29% YoY and EBIT up 193% YoY. Exports contributed 28.5% of revenue. The company also received NMPA approval for its Clopidogrel API in China.